Dicot has submitted a new patent application
News: Uppsala, October 17, 2022. Dicot AB announces today that the company has submitted a new patent application to the Patent and Registration Office. This is according to the IP plan previously communicated by the company. New patents provide 20 years of market exclusivity from the time an application is submitted.Dicot is developing a new potency drug, LIB-01, which aims to become the first choice for the treatment of erectile dysfunction and premature ejaculation. The company announced earlier this year that it has identified new patent opportunities for LIB-01 and that a new patent